skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > alpha-neuac-(2->6)-[alpha-neuac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > ceramide > oligoglycosylceramide > glycoheptaosylceramide > alpha-neuac-(2->6)-(alpha-neuac-(2->3))-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-neuac-(2->6)-[alpha-neuac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > ceramide > oligoglycosylceramide > glycoheptaosylceramide > alpha-neuac-(2->6)-(alpha-neuac-(2->3))-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-neuac-(2->6)-[alpha-neuac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > sphingolipid > ceramide > oligoglycosylceramide > glycoheptaosylceramide > alpha-neuac-(2->6)-(alpha-neuac-(2->3))-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-neuac-(2->6)-[alpha-neuac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > ceramide > oligoglycosylceramide > glycoheptaosylceramide > alpha-neuac-(2->6)-(alpha-neuac-(2->3))-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-neuac-(2->6)-[alpha-neuac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > carboxamide > ceramide > oligoglycosylceramide > glycoheptaosylceramide > alpha-neuac-(2->6)-(alpha-neuac-(2->3))-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-neuac-(2->6)-[alpha-neuac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > ceramide > oligoglycosylceramide > glycoheptaosylceramide > alpha-neuac-(2->6)-(alpha-neuac-(2->3))-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-neuac-(2->6)-[alpha-neuac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycoheptaosylceramide > alpha-neuac-(2->6)-(alpha-neuac-(2->3))-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-neuac-(2->6)-[alpha-neuac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycoheptaosylceramide > alpha-neuac-(2->6)-(alpha-neuac-(2->3))-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-neuac-(2->6)-[alpha-neuac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycoheptaosylceramide > alpha-neuac-(2->6)-(alpha-neuac-(2->3))-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-neuac-(2->6)-[alpha-neuac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycoheptaosylceramide > alpha-neuac-(2->6)-(alpha-neuac-(2->3))-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-neuac-(2->6)-[alpha-neuac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > sphingolipid > glycosphingolipid > neutral glycosphingolipid > oligoglycosylceramide > glycoheptaosylceramide > alpha-neuac-(2->6)-(alpha-neuac-(2->3))-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-neuac-(2->6)-[alpha-neuac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > liposaccharide > glycolipid > glycosphingolipid > globoside > alpha-neuac-(2->6)-(alpha-neuac-(2->3))-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-neuac-(2->6)-[alpha-neuac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > liposaccharide > glycolipid > glycosphingolipid > globoside > alpha-neuac-(2->6)-(alpha-neuac-(2->3))-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-neuac-(2->6)-[alpha-neuac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > lipid > sphingolipid > glycosphingolipid > globoside > alpha-neuac-(2->6)-(alpha-neuac-(2->3))-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-neuac-(2->6)-[alpha-neuac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > sphingolipid > glycosphingolipid > globoside > alpha-neuac-(2->6)-(alpha-neuac-(2->3))-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-neuac-(2->6)-[alpha-neuac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)
... > organooxygen compound > sphingolipid > glycosphingolipid > globoside > alpha-neuac-(2->6)-(alpha-neuac-(2->3))-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-cer > alpha-neuac-(2->6)-[alpha-neuac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)

اصطلاح مرجح

alpha-neuac-(2->6)-[alpha-neuac-(2->3)]-beta-d-gal-(1->3)-beta-d-galnac-(1->3)-alpha-d-gal-(1->4)-beta-d-gal-(1->4)-beta-d-glc-(1<->1')-ceramide(t18:0)  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • -2

فرمول

  • C73H123N4O45R

والد-عملکردی دارد

جرم

  • 1776.760

جرم تک‌ایزوتوپی

  • 1775.74593

اسمایلٓ

  • [C@H]([C@@H]([C@@H](CCCCCCCCCCCCCC)O)O)(NC(=O)*)CO[C@@H]1O[C@@H]([C@@H](O[C@@H]2O[C@@H]([C@H](O[C@@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@H]([C@H]([C@H](O4)CO)O)O[C@H]5[C@@H]([C@@H](O[C@]6(O[C@@]([C@@H]([C@H](C6)O)NC(C)=O)([H])[C@@H]([C@@H](CO)O)O)C([O-])=O)[C@H]([C@@H](CO[C@]7(O[C@@]([C@@H]([C@H](C7)O)NC(C)=O)([H])[C@@H]([C@@H](CO)O)O)C([O-])=O)O5)O)O)NC(C)=O)[C@H]([C@@H](CO)O3)O)O)[C@@H]([C@H]2O)O)CO)[C@@H]([C@H]1O)O)CO

زیرمجموعه

  • 2_STAR

مترادف مرتبط

  • alpha-NeuAc-(2->6)-[alpha-NeuAc-(2->3)]-beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer(t18:0)
  • globoside NeuAc(alpha2-6)-MSGG (t18:0)
  • N-acetyl-alpha-neuraminosyl-(2->6)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide(t18:0)
  • N-acetyl-alpha-neuraminosyl-(2->6)-[N-acetyl-alpha-neuraminosyl-(2->3)]-beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-acyl-(4R)-hydroxysphinganine
  • NeuAc(a2-6)-MSGG(t18:0)

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:141040

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD